In Vitro Testing of Gallium Citrate Against Bacterial Select Agent Pathogens
$36,639Y01FY2015AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This agreement will support the product development of inhaled gallium citrate as a novel first in class antimicrobial to treat bacterial infections.
View original record on NIH RePORTER →